Q2 2018 13F Holders as of 6/30/2018
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
55.5M
-
Number of holders
-
124
-
Total 13F shares, excl. options
-
29.1M
-
Shares change
-
+2.11M
-
Total reported value, excl. options
-
$569M
-
Value change
-
+$41.4M
-
Put/Call ratio
-
0.66
-
Number of buys
-
77
-
Number of sells
-
-37
-
Price
-
$19.54
Significant Holders of Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) as of Q2 2018
136 filings reported holding VYGR - Voyager Therapeutics, Inc. - Common Stock, $0.001 par value as of Q2 2018.
Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) has 124 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 29.1M shares
of 55.5M outstanding shares and own 52.45% of the company stock.
Largest 10 shareholders include TRV GP III, LLC (7.89M shares), BB BIOTECH AG (2.53M shares), FMR LLC (2.33M shares), BlackRock Inc. (1.85M shares), STATE STREET CORP (1.23M shares), Casdin Capital, LLC (1.14M shares), VANGUARD GROUP INC (1.08M shares), HIGHLINE CAPITAL MANAGEMENT, L.P. (841K shares), FARALLON CAPITAL MANAGEMENT LLC (768K shares), and GREAT POINT PARTNERS LLC (730K shares).
This table shows the top 124 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.